See more : BAB, Inc. (BABB) Income Statement Analysis – Financial Results
Complete financial analysis of CBD of Denver Inc. (CBDD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CBD of Denver Inc., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Aptorum Group Limited (APM) Income Statement Analysis – Financial Results
- Hanwha Investment & Securities Co., Ltd. (003535.KS) Income Statement Analysis – Financial Results
- Kec Corporation (092220.KS) Income Statement Analysis – Financial Results
- Needs Well Inc. (3992.T) Income Statement Analysis – Financial Results
- Pilani Investment and Industries Corporation Limited (PILANIINVS.BO) Income Statement Analysis – Financial Results
CBD of Denver Inc. (CBDD)
About CBD of Denver Inc.
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.98M | 2.34M | 22.85M | 16.00M | 25.08K | 0.00 | 0.00 | 0.00 | 5.04K | 42.50 |
Cost of Revenue | 2.82M | 3.01M | 22.61M | 14.59M | 17.32K | 0.00 | 0.00 | 388.00 | 0.00 | 31.00 |
Gross Profit | 165.48K | -669.60K | 240.52K | 1.41M | 7.76K | 0.00 | 0.00 | -388.00 | 5.04K | 11.50 |
Gross Profit Ratio | 5.55% | -28.56% | 1.05% | 8.79% | 30.93% | 0.00% | 0.00% | 0.00% | 100.00% | 27.06% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 429.36K | 2.08M | 566.08K | 199.09K | 117.56K | 190.09K | 10.16K | 81.00K | 257.63K | 308.97 |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 429.36K | 2.08M | 566.08K | 199.09K | 117.56K | 190.09K | 10.16K | 81.00K | 257.63K | 308.97 |
Cost & Expenses | 3.25M | 5.09M | 23.18M | 14.79M | 134.89K | 190.09K | 10.16K | 81.39K | 257.63K | 339.97 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 205.85 |
Interest Expense | 113.84K | 3.43K | 4.67K | 178.39K | 0.00 | 6.09K | 8.15K | 8.17K | 0.00 | 0.00 |
Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 2.58K | 171.86K | 161.14K | 52.52K | 388.00 | 0.00 | 1.54 |
EBITDA | 697.77K | -3.25M | -299.98K | 1.21M | 291.15K | 603.13K | -10.16K | -81.00K | -252.58K | -295.93K |
EBITDA Ratio | 23.40% | -117.20% | -1.42% | 7.57% | -437.87% | 0.00% | 0.00% | 0.00% | -5,007.53% | -696.30% |
Operating Income | -263.89K | -2.75M | -325.56K | 1.21M | -109.81K | -190.09K | -10.16K | -81.39K | -252.58K | -297.47 |
Operating Income Ratio | -8.85% | -117.20% | -1.42% | 7.55% | -437.87% | 0.00% | 0.00% | 0.00% | -5,007.53% | -699.92% |
Total Other Income/Expenses | 847.81K | -510.21K | 20.92K | -178.39K | 400.96K | 787.13K | -8.14K | -8.17K | 0.00 | -205.85 |
Income Before Tax | 583.92K | -3.26M | -304.64K | 1.03M | 291.15K | 597.04K | -18.30K | -89.56K | -252.58K | -503.32 |
Income Before Tax Ratio | 19.58% | -138.97% | -1.33% | 6.43% | 1,160.98% | 0.00% | 0.00% | 0.00% | -5,007.55% | -1,184.28% |
Income Tax Expense | 344.00 | -6.30K | -68.45K | 250.10K | -171.86K | -161.14K | -52.52K | 1.00 | 0.00 | 0.00 |
Net Income | 583.58K | -3.25M | -236.19K | 779.14K | 291.15K | 597.04K | -18.30K | -89.56K | -252.58K | -503.32 |
Net Income Ratio | 19.57% | -138.70% | -1.03% | 4.87% | 1,160.98% | 0.00% | 0.00% | 0.00% | -5,007.55% | -1,184.28% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 6.38B | 5.70B | 5.25B | 4.65B | 3.91B | 3.90B | 3.90B | 3.90B | 3.90B | 472.16K |
Weighted Avg Shares Out (Dil) | 16.70B | 5.70B | 5.25B | 19.85B | 14.26B | 3.90B | 3.90B | 3.90B | 3.90B | 471.91K |
CBD of Denver Inc. Reports Q2 2023 Financial and Business Highlights
CDB Of Denver, Inc. Announces Investor Call
CBD of Denver (CBDD) Expands on the Plans for Luxora Operations and Initiates Strategic Plans for Both Subsidiaries
CBD of Denver Signs the Agreement to Acquire LUXORA Holding AG
CBD of Denver Wants to Provide an Update on Progress with the Company and Additional Corporate Updates
CBD of Denver Files to Change Name and Symbol Change to Berliner Innovation and Provide Additional Corporate Updates
10 Penny Stocks You Can Have for Less Than a Dime
CBD of Denver Reports Revenue of $2.6 Million in September on 26.5% Growth in Product Sold
CBD of Denver Retires Preferred Shares Early, Eliminates Potential Equity Dilution
CBD of Denver Comments on Italy's Cannabis Referendum
Source: https://incomestatements.info
Category: Stock Reports